Neuromarkers of fatigue and cognitive complaints following chemotherapy for breast cancer: a prospective fMRI investigation

Breast Cancer Research and Treatment

Volumn 147, Issue 2, 2014, Pages 445-455

  Askren, Mary K ^a   Jung, Misook ^b,c   Berman, Marc G ^d   Zhang, Min ^b   Therrien, Barbara ^b   Peltier, Scott ^b   Ossher, Lynn ^b   Hayes, Daniel F ^b   Reuter Lorenz, Patricia A ^b   Cimprich, Bernadine ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c Chungnam National University   (South Korea)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

Breast cancer; Cognitive dysfunction; Executive function; Fatigue; Functional magnetic resonance imaging (fMRI); Working memory

Indexed keywords

BIOLOGICAL MARKER;

ADJUVANT CHEMOTHERAPY; ADVERSE EVENT; BREAST TUMOR; COGNITION; COGNITIVE DEFECT; DRUG EFFECT; FATIGUE; FEMALE; HUMAN; LONGITUDINAL STUDY; METABOLISM; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PROCEDURES; PROSPECTIVE STUDY; PSYCHOLOGY; SHORT TERM MEMORY;

BIOMARKERS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COGNITION; COGNITION DISORDERS; FATIGUE; FEMALE; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MEMORY, SHORT-TERM; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES;

EID: 84930011739     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-014-3092-6     Document Type: Article

References (41)

1. Wefel JS, Schagen SB (2012) Chemotherapy-related cognitive dysfunction. Curr Neurol Neurosci Rep 12:267–275. doi:10.1007/s11910-012-0264-9
2. Wefel JS, Vardy J, Ahles T, Schagen SB (2011) International cognition and cancer task force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol 12:703–708. doi:10.1016/S1470-2045(10)70294-1
3. Ruzich M, Ryan B, Owen C et al (2007) Prospective evaluation of cognitive function in patients with early breast cancer receiving adjuvant chemotherapy. Asia Pac J Clin Oncol 3:125–133
4. Tager FA, McKinley PS, Schnabel FR et al (2010) The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study. Breast Cancer Res Treat 123:25–34. doi:10.1007/s10549-009-0606-8
5. Hedayati E, Alinaghizadeh H, Schedin A et al (2012) Effects of adjuvant treatment on cognitive function in women with early breast cancer. Eur J Oncol Nurs 16:315–322. doi:10.1016/j.ejon.2011.07.006
6. Wefel JS, Lenzi R, Theriault RL et al (2004) The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer 100:2292–2299. doi:10.1002/cncr.20272
7. Hermelink K, Untch M, Lux MP et al (2007) Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study. Cancer 109:1905–1913. doi:10.1002/cncr.22610
8. Reuter-Lorenz P, Cimprich B (2013) Cognitive function and breast cancer: promise and potential insights from functional brain imaging. Breast Cancer Res Treat 137:33–43. doi:10.1007/s10549-012-2266-3
9. Wefel JS, Saleeba AK, Buzdar AU, Meyers CA (2010) Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer 116:3348–3356. doi:10.1002/cncr.25098
10. Jim HS, Phillips KM, Chait S et al (2012) Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy. J Clin Oncol 30:3578–3587. doi:10.1200/JCO.2011.39.5640
11. Cimprich B, Reuter-Lorenz P, Nelson J et al (2010) Prechemotherapy alterations in brain function in women with breast cancer. J Clin Exp Neuropsychol 32:324–331. doi:10.1080/13803390903032537
12. Ahles TA, Saykin AJ, McDonald BC et al (2008) Cognitive function in breast cancer patients prior to adjuvant treatment. Breast Cancer Res Treat 110:143–152. doi:10.1007/s10549-007-9686-5
13. Scherling C, Collins B, Mackenzie J et al (2011) Pre-chemotherapy differences in visuospatial working memory in breast cancer patients compared to controls: an FMRI study. Front Hum Neurosci 5:122. doi:10.3389/fnhum.2011.00122
14. Bower JE, Lamkin DM (2013) Inflammation and cancer-related fatigue: mechanisms, contributing factors, and treatment implications. Brain Behav Immun 30(Suppl):S48–S57. doi:10.1016/j.bbi.2012.06.011
15. Ganz PA, Bower JE, Kwan L et al (2013) Does tumor necrosis factor-alpha (TNF-alpha) play a role in post-chemotherapy cerebral dysfunction? Brain Behav Immun 30(Suppl):S99–S108. doi:10.1016/j.bbi.2012.07.015
16. Kaplan S, Berman MG (2010) Directed attention as a common resource for executive functioning and self-regulation. Psychol Sci 5:43–57
17. Berger AM, Gerber LH, Mayer DK (2012) Cancer-related fatigue: implications for breast cancer survivors. Cancer 118:2261–2269. doi:10.1002/cncr.27475
18. De Jong N, Candel MJ, Schouten HC et al (2004) Prevalence and course of fatigue in breast cancer patients receiving adjuvant chemotherapy. Ann Oncol 15:896–905
19. Noal S, Levy C, Hardouin A et al (2011) One-year longitudinal study of fatigue, cognitive functions, and quality of life after adjuvant radiotherapy for breast cancer. Int J Radiat Oncol Biol Phys 81:795–803. doi:10.1016/j.ijrobp.2010.06.037
20. Minton O, Stone PC (2013) A comparison of cognitive function, sleep and activity levels in disease-free breast cancer patients with or without cancer-related fatigue syndrome. BMJ Support Palliat Care 2:231–238. doi:10.1136/bmjspcare-2011-000172
21. Mehnert A, Scherwath A, Schirmer L et al (2007) The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy. Patient Educ Counseling 66:108–118. doi:10.1016/j.pec.2006.11.005
22. Ferguson RJ, McDonald BC, Saykin AJ, Ahles TA (2007) Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy. J Clin Oncol 25:3866–3870. doi:10.1200/JCO.2007.10.8639
23. De Ruiter MB, Reneman L, Boogerd W et al (2011) Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer. Hum Brain Mapp 32:1206–1219. doi:10.1002/hbm.21102
24. Kesler SR, Kent JS, O’Hara R (2011) Prefrontal cortex and executive function impairments in primary breast cancer. Arch Neurol 68:1447–1453. doi:10.1001/archneurol.2011.245
25. McDonald BC, Conroy SK, Ahles TA et al (2012) Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study. J Clin Oncol. doi:10.1200/JCO.2011.38.5674
26. Heeger DJ, Ress D (2002) What does fMRI tell us about neuronal activity? Nat Rev Neurosci 3:142–151. doi:10.1038/nrn730
27. Logothetis NK, Pfeuffer J (2004) On the nature of the BOLD fMRI contrast mechanism. Magn Reson Imaging 22:1517–1531. doi:10.1016/j.mri.2004.10.018
28. Reuter-Lorenz PA, Cappell KA (2008) Neurocognitive aging and the compensation hypothesis. Curr Dir Psychol Sci 17:177–182. doi:10.1111/j.1467-8721.2008.00570.x
29. Berman MG, Nee DE, Casement M et al (2011) Neural and behavioral effects of interference resolution in depression and rumination. Cogn Affect Behav Neurosci 11:85–96. doi:10.3758/s13415-010-0014-x
30. Kroenke K, Strine TW, Spitzer RL et al (2009) The PHQ-8 as a measure of current depression in the general population. J Affect Disord 114:163–173. doi:10.1016/j.jad.2008.06.026
31. Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198
32. Berman MG, Askren MK, Sook Jung M et al (2013) Pretreatment worry and neurocognitive responses in women with breast cancer. Health Psychol. doi:10.1037/a0033425
33. Yellen SB, Cella DF, Webster K et al (1997) Measuring fatigue and other anemia-related symptoms with the functional assessment of cancer therapy (FACT) measurement system. J Pain Symptom Manage 13:63–74. doi:10.1016/S0885-3924(96)00274-6
34. Cimprich B, Visovatti M, Ronis DL (2011) The attentional function index—a self-report cognitive measure. Psychooncology 20:194–202. doi:10.1002/pon.1729
35. Kelly WE (2004) A brief measure of general worry: the three item worry index. North Am J Psychol 6:219–225
36. Nelson JK, Reuter-Lorenz PA, Sylvester C-YC et al (2003) Dissociable neural mechanisms underlying response-based and familiarity-based conflict in working memory. Proc Natl Acad Sci 100:11171–11175. doi:10.1073/pnas.1334125100
37. Belle S, Paridaens R, Evers G et al (2005) Comparison of proposed diagnostic criteria with FACT-F and VAS for cancer-related fatigue: proposal for use as a screening tool. Support Care Cancer 13:246–254. doi:10.1007/s00520-004-0734-y
38. Depue BE, Burgess GC, Willcutt EG et al (2010) Symptom-correlated brain regions in young adults with combined-type ADHD: their organization, variability, and relation to behavioral performance. Psychiatry Res Neuroimaging 182:96–102. doi:10.1016/j.pscychresns.2009.11.011
39. Garrett DD, Kovacevic N, McIntosh AR, Grady CL (2013) The modulation of BOLD variability between cognitive states varies by age and processing speed. Cereb Cortex 23:684–693
40. Berman MG, Yourganov G, Askren MK et al (2013) Dimensionality of brain networks linked to life-long individual differences in self-control. Nat Commun 4:1373. doi:10.1038/ncomms2374
41. Deprez S, Vandenbulcke M, Peeters R et al (2014) Longitudinal assessment of chemotherapy-induced alterations in brain activation during multitasking and its relation with cognitive complaints. J Clin Oncol 32:2031–2038. doi:10.1200/JCO.2013.53.6219